Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

Details for Australian Patent Application No. 2012211398 (hide)

Owner Alnylam Pharmaceuticals, Inc. The Rockefeller University

Inventors Manoharan, Muthiah; Stoffel, Markus; Rajeev, Kallanthottathil G.

Agent Pizzeys

Pub. Number AU-A-2012211398

Parent 2006279906

Filing date 8 August 2012

Wipo publication date 23 August 2012

International Classifications

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

23 August 2012 Application Open to Public Inspection

  Published as AU-A-2012211398

23 August 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012211399-Herbicidal compositions as dispersions comprising diflufenican and flurtamone

2012211397-Compositions and Processes for Preparing 13-Deoxy-Anthracyclies